Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Dowell

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
JTO Clinical and Research Reports|May 15, 2024
Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with <i>KRAS</i> G12C-Mutated NSCLCKatherine I Zhou, Chenyu Lin, Chin-Lin Tseng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2011
Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acidSachin R Shah, Gary W Jean, Sidney V Keisner, et al.
The Prostate|October 9, 2025
Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data CoreErum Z Whyne, Sung-Hee Choi, Nisha Unni, et al.
Surgery|May 13, 2015
Phase I dose escalation trial of nitroglycerin in addition to 5-fluorouracil and radiation therapy for neoadjuvant treatment of operable rectal cancerHenrik Illum, David H Wang, Jonathan E Dowell, et al.
Targeted Oncology|August 21, 2019
Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical TrialAli A Mokdad, Hao Zhu, Muhammad S Beg, et al.
The Oncologist|April 30, 2009
The impact of consenter characteristics and experience on patient interest in clinical researchDrew W Rasco, Yang Xie, Jingsheng Yan, et al.
Journal of Oncology Practice|October 19, 2012
Consent timing and experience: modifiable factors that may influence interest in clinical researchDavid E Gerber, Drew W Rasco, Celette Sugg Skinner, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2012
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesotheliomaJonathan E Dowell, Frank R Dunphy, Robert N Taub, et al.
Lung Cancer (Amsterdam, Netherlands)|July 9, 2023
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancerSheena Bhalla, Farjana J Fattah, Chul Ahn, et al.
JAMA Oncology|October 4, 2017
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialPuneeth Iyengar, Zabi Wardak, David E Gerber, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
JTO Clinical and Research Reports|May 15, 2024
Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with <i>KRAS</i> G12C-Mutated NSCLCKatherine I Zhou, Chenyu Lin, Chin-Lin Tseng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 4, 2011
Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acidSachin R Shah, Gary W Jean, Sidney V Keisner, et al.
The Prostate|October 9, 2025
Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data CoreErum Z Whyne, Sung-Hee Choi, Nisha Unni, et al.
Surgery|May 13, 2015
Phase I dose escalation trial of nitroglycerin in addition to 5-fluorouracil and radiation therapy for neoadjuvant treatment of operable rectal cancerHenrik Illum, David H Wang, Jonathan E Dowell, et al.
Targeted Oncology|August 21, 2019
Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical TrialAli A Mokdad, Hao Zhu, Muhammad S Beg, et al.
The Oncologist|April 30, 2009
The impact of consenter characteristics and experience on patient interest in clinical researchDrew W Rasco, Yang Xie, Jingsheng Yan, et al.
Journal of Oncology Practice|October 19, 2012
Consent timing and experience: modifiable factors that may influence interest in clinical researchDavid E Gerber, Drew W Rasco, Celette Sugg Skinner, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2012
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesotheliomaJonathan E Dowell, Frank R Dunphy, Robert N Taub, et al.
Lung Cancer (Amsterdam, Netherlands)|July 9, 2023
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancerSheena Bhalla, Farjana J Fattah, Chul Ahn, et al.
JAMA Oncology|October 4, 2017
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical TrialPuneeth Iyengar, Zabi Wardak, David E Gerber, et al.
Pageof 6